A community survey of people interested in PrEP in the UK, run in October and November 2020, shows an increase in access to PrEP compared to previous surveys, alongside numerous other changes that may reflect the impact of the coronavirus pandemic. Respondents reported more event-based dosing, fewer sexual partners and less sexual satisfaction. PrEPster, iwantPrEPnow,… Read More »
Australian doctors and nurses discuss PrEP’s role in tackling stigma, supporting U=U, and improving mental health Do doctors and other healthcare workers feel it’s legitimate to prescribe PrEP to people who are anxious about catching HIV, even if their actual risk is low? This question has been rarely been systematically asked of doctors and other… Read More »
HPTN 084 study finds significantly lower adherence in women taking daily PrEP pills A second study of an injectable HIV drug used to prevent HIV has had its randomised phase stopped early after it became clear that giving women a two-monthly injection of a prevention drug resulted in nearly nine times fewer infections than giving… Read More »
The 17th European AIDS Conference (EACS 2019) in Basel, Switzerland, last week, heard about another case of a PrEP user who caught HIV despite being apparently adherent to PrEP. These cases are likely to keep on happening, Dr Hans Benjamin Hampel of Zürich University Hospital told the conference, and we perhaps need to move beyond trying to… Read More »
New cases of hepatitis C virus (HCV) infection among Canadian gay and bisexual men taking pre-exposure prophylaxis (PrEP) were uncommon compared with rates previously reported in Europe, according to research presented this week at the AASLD Liver Meeting in Boston. “This low incidence is reassuring since studies have shown that risk behaviour associated with sexually… Read More »